Virtual Incision
Lincoln, US · Founded 2006 · Delaware corporation · 32 employees on LinkedIn · 6 known investors
Virtual Incision develops a miniaturized robotic-assisted surgery (miniRAS) system called MIRA, designed to fit within hospitals' existing infrastructure. The company targets patients, surgeons, and healthcare facilities in the surgical robotics and medical device market.
Founders & leadership
Virtual Incision was founded in 2006 by Dmitry Oleynikov and Shane Farritor.
DO
Dmitry OleynikovCo-founder
SF
Shane FarritorCo-founder
JP
John P. MurphyExecutive
MS
Mukund SrinivasanExecutive
Board
TS
Tom ShehabBoard director
FR
Fred RobertsonBoard director
TL
Tao LinBoard director
FP
Fernando PachecoBoard director
TS
Tyler StowaterBoard director
MJ
SK
Steve KirbyBoard director
Investors · 6
Reported raises · per SEC filings
Form D private placements$99M disclosed across 8 of 9 rounds · 2015–2026
▶$7.9MraisedMay 2025 · 62 investors · BiotechnologyRule 506(b)
▶$7.9MraisedMay 2025 · 62 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tom ShehabDirector
- Fred RobertsonDirector
- Tao LinDirector
- John P. MurphyExecutive Officer, Director
- Fernando PachecoDirector
- Mukund SrinivasanExecutive Officer
- Tyler StowaterDirector
- Offering amount
- $25M
- Amount sold
- $7.9M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11MraisedJun 2023 · 33 investors · BiotechnologyRule 506(b)
▶$11MraisedJun 2023 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Fernando PachecoDirector
- John P. MurphyExecutive Officer, Director
- Tao LinDirector
- Tyler StowaterDirector
- Mukund SrinivasanExecutive Officer
- Fred RobertsonDirector
- Offering amount
- $22.5M
- Amount sold
- $11M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$46.6MraisedDec 2021 · 62 investors · BiotechnologyRule 506(b)
▶$46.6MraisedDec 2021 · 62 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rob BarmannDirector
- Lewei WangDirector
- Amy KobeDirector
- John P. MurphyExecutive Officer, Director
- Tyler StowaterDirector
- Offering amount
- $46.6M
- Amount sold
- $46.6M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedOct 2021 · 15 investors · BiotechnologyRule 506(b)
▶$4MraisedOct 2021 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lewei WangDirector
- Mike JerstadDirector
- Shane FarritorExecutive Officer, Director
- John P. MurphyExecutive Officer, Director
- Tyler StowaterDirector
- Steve KirbyDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.1MraisedOct 2019 · 14 investors · BiotechnologyRule 506(b)
▶$10.1MraisedOct 2019 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shane FarritorExecutive Officer, Director
- John P. MurphyExecutive Officer, Director
- Sandy HorstDirector
- Steve KirbyDirector
- Mike JerstadDirector
- Shi ShenghaoDirector
- Offering amount
- $25M
- Amount sold
- $10.1M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.3MraisedAug 2019 · 5 investors · BiotechnologyRule 506(b)
▶$2.3MraisedAug 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shane FarritorExecutive Officer, Director
- Steve KirbyDirector
- John P. MurphyExecutive Officer, Director
- Shi ShenghaoDirector
- Sandy HorstDirector
- Mike JerstadDirector
- Offering amount
- $3M
- Amount sold
- $2.3M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.3MraisedDec 2017 · BiotechnologyRule 506(b)
▶$15.3MraisedDec 2017 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sandy HorstDirector
- John MurphyExecutive Officer, Director
- Shane FarritorExecutive Officer, Director
- Steve KirbyDirector
- Mike JerstadDirector
- Offering amount
- $18.3M
- Amount sold
- $15.3M
- Minimum investment
- $65.2K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedJul 2015 · 5 investors · BiotechnologyRule 506(b)
▶$1.8MraisedJul 2015 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dmitry OleynikovDirector
- Mike JerstadDirector
- John MurphyExecutive Officer, Director
- Steve KirbyDirector
- Shane FarritorExecutive Officer, Director
- Offering amount
- $4.4M
- Amount sold
- $1.8M
- Minimum investment
- $50K
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlapIntuitive35 shared keywordsIntuitive develops robotic-assisted surgical systems, including the da Vinci systems for minimally invasive surgery and the Ion system for bronchoscopy. Its products are medical devices used by surgeons and physicians in healthcare settings.
Vicarious Surgical32 shared keywordsVicarious Surgical develops a surgical robot for minimally invasive laparoscopic procedures, providing surgeons with 3D visualization and precise control. The system, which has received FDA Breakthrough Device Designation, targets hospitals, surgeons, and patients seeking advanced surgical care.
Rf Surgical23 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Moon Surgical17 shared keywordsMoon Surgical develops the Maestro robotic surgery system, a digital surgical robotics platform used by surgeons to perform procedures. The company, with a French-American team, has received FDA clearance and CE mark for its system.
Horizonsurgicalsystems16 shared keywordsHorizon Surgical Systems develops assistive microsurgical robotics with real-time 3D multimodal imaging and machine learning to support surgeons performing cataract surgery. Its technology, including the Polaris product, aims to improve precision and consistency of eye care in the U.S.
Uclahealth16 shared keywordsUCLA Health is an academic health system providing primary, immediate, and specialty medical care including cancer, neuroscience, transplant, orthopedics, cardiovascular, and children's care. It operates hospitals and clinics and trains medical students, with a network of locations in the Los Angeles area.
Companies competing with Virtual Incision for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Virtual Incision do?
- Virtual Incision develops a miniaturized robotic-assisted surgery (miniRAS) system called MIRA, designed to fit within hospitals' existing infrastructure. The company targets patients, surgeons, and healthcare facilities in the surgical robotics and medical device market.
- Who founded Virtual Incision?
- Virtual Incision was founded by Dmitry Oleynikov, Shane Farritor in 2006.
- Who are Virtual Incision's investors?
- Virtual Incision's investors include Arboretum Ventures, Invest Nebraska, InVivium Capital, Baird Capital, Endeavour Vision, PrairieGold Venture Partners.
- How much funding has Virtual Incision raised?
- Virtual Incision has disclosed $99M raised across 8 of its 9 known rounds.
- Where is Virtual Incision headquartered?
- Virtual Incision is headquartered in Lincoln, US.